Skip to main content

Tusnel

NDC 54859-544 · Llorens Pharmaceutical International Division

Generic nameDextromethorphan, Guiafenesin, Pseudoephedrine HCl
Dosage formLIQUID
RouteORAL
Active ingredient(s)DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE
Strength5; 50; 15 mg/5mL; mg/5mL; mg/5mL
Pharmacologic classAdrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]
Marketing categoryOTC MONOGRAPH DRUG

Packages

54859-544-04 — 118 mL in 1 BOTTLE (54859-544-04)

54859-544-16 — 473 mL in 1 BOTTLE (54859-544-16)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

54859-011 — Dextromethorphan HBr, Guaifenesin, 54859-502 — Dextromethorphan, Guiafenesin, Pseudoephedrine HCl, 54859-505 — Dextromethorphan, Guaifenesin, 54859-506 — Dextromethorphan HBr, Guaifenesin, 54859-507 — Guaifenesin, 54859-508 — Dextromethorphan HBr, Phenylephrine HCl, Triprolidine HCl, 54859-509 — Dextromethorphan HBr, Guaifenesin, 54859-510 — Guaifenesin, 54859-514 — Dextromethorphan HBr, Pseufoephedrine HCl, Triprolidine HCl, 54859-517 — Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 54859-603 — Dextromethorphan, Guiafenesin, Pseudoephedrine HCl, 54859-604 — Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 54859-605 — Guaifenesin, Phenylephrine HCl, 54859-606 — Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 54859-803 — Dexbrompheniramine Maleate, Pseudoephedrine HCl, 54859-812 — Dexbrompheniramine Maleate, Pseudoephedrine HCl, 54859-833 — Dextromethorphan HBr, Guaifenesin, 55111-447 — Fexofenadine HCl and Pseudoephedrine HCI, 55111-557 — Fexofenadine HCl and Pseudoephedrine HCI, 55111-798 — Guaifenesin and Pseudoephedrine HCL, +2717 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels